DrugPatentWatch Database Preview
Details for Patent: 9,339,504
Try a free trial
See Plans and Pricing
Which drugs does patent 9,339,504 protect, and when does it expire?
Patent 9,339,504 protects LAMICTAL ODT and is included in one NDA.
This patent has seventeen patent family members in twelve countries.
Summary for Patent: 9,339,504
| Title: | Orally disintegrating tablet compositions of lamotrigine |
| Abstract: | The compositions of the present invention composition comprise a therapeutically effective amount of particles comprising lamotrigine, in combination with granules comprising a disintegrant, and a sugar alcohol and/or a saccharide. These compositions are useful in treating epilepsy and bipolar disorder, particularly for patients with dysphagia, and to improve compliance with bipolar patients. |
| Inventor(s): | Venkatesh; Gopi M. (Vandalia, OH), Vyas; Nehal H. (Yardley, PA), Gosselin; Michael (Springboro, OH), Lai; Jin-Wang (Springboro, OH) |
| Assignee: | ADARE PHARMACEUTICALS, INC. (Lawrenceville, NJ) |
| Application Number: | 14/172,962 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 9,339,504
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline Llc | LAMICTAL ODT | lamotrigine | TABLET, ORALLY DISINTEGRATING;ORAL | 022251-001 | May 8, 2009 | AB | RX | Yes | No | Try a Free Trial | Try a Free Trial | Y | LAMICTAL IS AN ANTIEPILEPTIC DRUG (AED) INDICATED FOR: EPILEPSY-ADJUNCTIVE THERAPY IN PATIENTS GREATER THAN OR EQUAL TO 2 YEARS OF AGE: (1.1) PARTIAL SEIZURES PRIMARY GENERALIZED TONIC-CLONIC SEIZURES | Try a Free Trial | ||
| Glaxosmithkline Llc | LAMICTAL ODT | lamotrigine | TABLET, ORALLY DISINTEGRATING;ORAL | 022251-004 | May 8, 2009 | AB | RX | Yes | No | Try a Free Trial | Try a Free Trial | Y | LAMICTAL IS AN ANTIEPILEPTIC DRUG (AED) INDICATED FOR: EPILEPSY-ADJUNCTIVE THERAPY IN PATIENTS GREATER THAN OR EQUAL TO 2 YEARS OF AGE: (1.1) PARTIAL SEIZURES PRIMARY GENERALIZED TONIC-CLONIC SEIZURES | Try a Free Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,339,504
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 068185 | Try a Free Trial | |||
| Australia | 2008272871 | Try a Free Trial | |||
| Brazil | PI0814408 | Try a Free Trial | |||
| Canada | 2693072 | Try a Free Trial | |||
| China | 101801192 | Try a Free Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
